Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Sigilon Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues12.99.613.448.121.0
            Revenue growth34.8%-28.2%-72.2%128.7% 
Cost of goods sold0.00.00.082.127.7
Gross profit12.99.613.4-34.0-6.7
            Gross margin100.0%100.0%100.0%-70.6%-31.7%
Research and development37.665.153.5  
General and administrative19.020.212.510.26.7
EBIT-43.7-75.6-52.6-44.1-23.1
            EBIT margin-337.3%-788.0%-393.6%-91.7%-109.7%
Pre-tax income-43.6-77.3-54.60.0-25.8
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%0.0% 0.0%
Net income-43.6-77.3-54.60.0-25.8
            Net margin-336.5%-805.4%-408.3%0.0%-122.4%
 
Diluted EPS($1.34)($2.43)($7.55)$0.00($9.19)
Shares outstanding (diluted)32.431.97.24,090.72.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy